Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
334 studies found for:    Open Studies | "Sarcoma"
Show Display Options
Rank Status Study
1 Recruiting Sarcoma Database at KFSH&RC
Condition: Sarcoma Database
Intervention: Other: Database
2 Recruiting A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: Gemcitabine and Pazopanib;   Drug: Gemcitabine and Docetaxel
3 Recruiting A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma
Condition: Ewing Sarcoma
Interventions: Biological: allogeneic stem cell transplantation;   Drug: Clyclophosphamide;   Drug: Fludarabina;   Drug: Busulfan;   Drug: Melphalan
4 Recruiting Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Standard treatment (as per protocol ISG SSG III);   Drug: Intensified chemotherapy
5 Recruiting Randomized Phase IIb Trial of Vigil™ Versus Gemcitabine + Docetaxel for Ewing's Sarcoma
Condition: Ewing's Sarcoma
Interventions: Biological: Vigil;   Drug: gemcitabine and docetaxel
6 Recruiting Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall
Condition: Soft Tissue Sarcoma
Intervention: Radiation: Hypofractionated Radiation Therapy
7 Recruiting iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma/VEGAS
Condition: Sarcomas
Interventions: Genetic: GD2 T cells;   Biological: VZV vaccine
8 Not yet recruiting A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma
Condition: Soft-tissue Sarcoma
Interventions: Drug: Olaparib;   Radiation: Concomitant Radiotherapy
9 Recruiting Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma
Condition: Sarcoma
Intervention: Other: PDX drug sensitivity testing
10 Recruiting Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
Condition: Sarcoma
Interventions: Genetic: Autologous HER2-specific T cells;   Drug: Fludarabine;   Drug: Cyclophosphamide
11 Recruiting Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
Condition: Sarcoma
Interventions: Drug: Docetaxel;   Drug: Gemcitabine;   Drug: Vorinostat;   Drug: Pegfilgrastim
12 Recruiting Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma
Condition: Sarcoma
Interventions: Procedure: therapeutic conventional surgery;   Radiation: 3-dimensional conformal radiation therapy
13 Recruiting Quantitative Imaging Biomarkers for Sarcoma
Condition: Sarcoma
Interventions: Procedure: DCE and DWI MRI;   Procedure: Surgery;   Device: MRI
14 Recruiting Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma
Condition: Sarcoma, Soft Tissue
Intervention: Other: Observational Only - Transcutaneous Oxygen Measurement
15 Recruiting Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Other: Specimen protocol
16 Recruiting Bevacizumab/Doxorubicin/Radiation for Sarcoma
Condition: Sarcoma
Interventions: Drug: Bevacizumab;   Drug: Doxorubicin;   Radiation: Radiation Therapy
17 Recruiting Retrospective Study of Trabectedin in Soft Tissue Sarcomas
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Trabectedin
18 Recruiting Advanced MR Imaging in Sarcoma Patients
Condition: Sarcoma
Intervention:
19 Recruiting A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall
Condition: Soft Tissue Sarcoma
Interventions: Radiation: proton radiation;   Procedure: surgery (wide local excision; limb preservation surgery)
20 Recruiting Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas
Condition: Sarcoma
Intervention: Drug: oral cyclophosphamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.